Testing effectiveness (Phase 2)Study completedNCT04143711What this trial is testingStudy of DF1001 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Dragonfly Therapeutics 270
Early research (Phase 1)Looking for participantsNCT04282044What this trial is testingStudy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesWho this might be right forSolid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more BioEclipse Therapeutics 60
Testing effectiveness (Phase 2)UnknownNCT03624309What this trial is testingAnlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Hunan Cancer Hospital 84
Testing effectiveness (Phase 2)Study completedNCT00864721What this trial is testingSunitinib Non Small Cell Lung Cancer Patients Over 70Who this might be right forNon Small Cell Lung Cancer US Oncology Research 63
Early research (Phase 1)Study completedNCT02000947What this trial is testingA Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung CancerWho this might be right forNSCLCNon-small Cell Lung CancerLung Cancer MedImmune LLC 459
Early research (Phase 1)Study completedNCT04925284What this trial is testingStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)Who this might be right forNon Small Cell Lung CancerCervical CancerSCCHN+8 more Exelixis 269
Not applicableWithdrawnNCT02891733What this trial is testingRetrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung AdenocarcinomasWho this might be right forMetastatic Lung Adenocarcinomas Fondation Hôpital Saint-Joseph
Large-scale testing (Phase 3)Active Not RecruitingNCT06031558What this trial is testingPhase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLCWho this might be right forNon-Small Cell Lung Cancer Shouyao Holdings (Beijing) Co. LTD 120
Large-scale testing (Phase 3)UnknownNCT01731548What this trial is testingA Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung CancerWho this might be right forCarcinoma of LungSmall CellLimited Stage Zhejiang Cancer Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00002506What this trial is testingIsotretinoin Plus Interferon in Treating Patients With Recurrent CancerWho this might be right forCervical CancerEsophageal CancerHead and Neck Cancer+3 more Hoag Memorial Hospital Presbyterian
Not applicableStudy completedNCT02695849What this trial is testingPrevalence of EGFR Mutations in Participants With NSCLCWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Ended earlyNCT04560686What this trial is testingBintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung CancerWho this might be right forResectable Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+8 more M.D. Anderson Cancer Center 2
Not applicableLooking for participantsNCT07751783What this trial is testingDevelopment and Dissemination of Exercise Prescription and Intervention for Cancer PopulationsWho this might be right forCancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Lung Cancer (Non-Small Cell)+2 more Kaohsiung Medical University Chung-Ho Memorial Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00003666What this trial is testingIrofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 36
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Study completedNCT00805194What this trial is testingLUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 1,314
Not applicableStudy completedNCT02619929What this trial is testingInitial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and AustriaWho this might be right forNon-Small-Cell Lung CancerBreast Cancer Pierre Fabre Pharma GmbH 108
Testing effectiveness (Phase 2)Study completedNCT00003037What this trial is testingCombination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung CancerWho this might be right forLung Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07622186What this trial is testingSKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)UnknownNCT06590194What this trial is testingPH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Who this might be right forAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Suzhou Puhe Pharmaceutical Technology Co., LTD 96